Stephanie Freeman covers this topic during February 18, 2021 SOC FOR MSY ECHO session. For more program information, visit: https://wraparoundohio.org/project-echo/
Tag: risk
Suicide: Risk & Protective Factors – Systems of Care ECHO for Multi-System Youth
Dr. Jeff Bridge from Nationwide Children’s Hospital shares his knowledge of this topic with the SOC FOR MSY Project ECHO session during February 11, 2021.
Suicide: Screening & Risk Assessment – Systems of Care ECHO for Multi-System Youth
Dr. John Ackerman from Nationwide Children’s Hospital shares his knowledge of this topic with the SOC FOR MSY Project ECHO session during February 4, 2021.
The Diabetic Foot: Prompt Identification of Risk to Prevent Complications in the Diabetic Foot
Michael Canales, DPM, FACFAS, from St. Vincent Charity Hospital shares his expertise regarding the diabetic foot and the value of teamwork in preventing adverse outcomes for patient with diabetes. For more information about the Integrated Care @ NEOMED (IC@N) ECHO program, visit https://libraryguides.neomed.edu/ICAN…The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.
Montelukast. What are the psychiatric adverse effect risks from this popular asthma/allergy medication and who is at risk?
In this video, Dr. Sara Dugan reviews the psychiatric side effects of montelukast, a medication commonly used to treat asthma. By the end of this lecture, you will be able to: 1) list the neuropsychiatric adverse effects associated with the use of montelukast and 2) identify populations that have reported these adverse effects.
Hyperprolactinemia: The medications that can cause it and what can be done about it.
In this lecture, Dr. Dugan discusses medications that commonly cause hyperprolactinemia and presents options for management. By the end of this lecture, you will be able to: 1) list the causes of elevated prolactin levels, 2) identify symptoms associated with elevated prolactin levels, and 3) compare the impact medications commonly used for mental health conditions have on prolactin levels.
MAO Inhibitors. How Do These Antidepressants Work and How to Use Them Safely
In this lecture, Dr. Dugan explains how the MAO inhibitors work and the mechanisms behind the potential risks. She also discusses the therapeutic benefits of these medications and how to use them safely. By the end of this lecture, you will be able to: 1) describe the mechanism of action of the monoamine oxidase inhibitors (MAOIs), 2) identify relevant interactions of MAOIs with medications and foods, and 3) evaluate efficacy data of MAOIs in treatment of depression.
Drug Interactions with Psychiatric Medications
In this lecture, Dr. Dugan covers the basics of drug metabolism and highlights several important psychiatric drug-drug interactions that patients as well as prescribers should be aware of. By the end of this lecture, you will be able to: 1) compare pharmacodynamic and pharmacokinetic drug interactions and 2) identify relevant drug interactions with medications used in the treatment of mental illnesses.
